State‐of‐the‐art human adenovirus vectorology for therapeutic approaches

Molecular Evolution of Human Adenovirus (HAdV) Species C

(2019) Akshay Dhingra et al.   Scientific Reports

The first identification of human adenovirus 57 (HAdV-57) in Japan

(2018) Chika Tatsumi et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors

(2018) Peter Abbink et al.   JOURNAL OF VIROLOGY

Seamless assembly of recombinant adenoviral genomes from high-copy plasmids

(2018) Jessica J. Miciak et al.   PLoS One

Seeing the Light after 25 Years of Retinal Gene Therapy

(2018) Ivana Trapani et al.   TRENDS IN MOLECULAR MEDICINE

CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy

(2018) Sadia Zafar et al.   OncoImmunology

Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

(2017) Dirk Grimm et al.   HUMAN GENE THERAPY

Advances in Gene Therapy for Hemophilia

(2017) Amit C. Nathwani et al.   HUMAN GENE THERAPY

Three novel, multiple recombinant types of species of human mastadenovirus D (HAdV-D 73, 74 & 75) isolated from diarrhoeal faeces of immunocompromised patients

(2017) Elias Hage et al.   JOURNAL OF GENERAL VIROLOGY

Chimpanzee Adenovirus Vector Ebola Vaccine

(2017) Julie E. Ledgerwood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Getting genetic access to natural adenovirus genomes to explore vector diversity

(2017) Wenli Zhang et al.   VIRUS GENES

An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity

(2017) Wenli Zhang et al.   Cell Reports

Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy

(2016) A-Rum Yoon et al.   Expert Opinion on Drug Delivery

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

(2016) Milagritos D Tapia et al.   LANCET INFECTIOUS DISEASES

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

(2016) I. Liikanen et al.   MOLECULAR CANCER THERAPEUTICS

Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs

(2016) Julio Alonso-Padilla et al.   MOLECULAR THERAPY

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

(2016) Katie Ewer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43

(2016) Natalya Belousova et al.   Oncotarget

Polymeric oncolytic adenovirus for cancer gene therapy

(2015) Joung-Woo Choi et al.   JOURNAL OF CONTROLLED RELEASE

Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses

(2015) Martin Mück-Häusl et al.   NUCLEIC ACIDS RESEARCH

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization

(2015) Surender Khurana et al.   PLoS One

Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development

(2015) Cheng Cheng et al.   VACCINE

Trial Watch—Oncolytic viruses and cancer therapy

(2015) Jonathan Pol et al.   OncoImmunology

Adenovirus Infections in Immunocompetent and Immunocompromised Patients

(2014) T. Lion   CLINICAL MICROBIOLOGY REVIEWS

Adenovirus: The First Effective In Vivo Gene Delivery Vector

(2014) Ronald G. Crystal   HUMAN GENE THERAPY

Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans

(2014) Lindsey R. Baden et al.   JOURNAL OF INFECTIOUS DISEASES

Novel vaccine vectors for HIV-1

(2014) Dan H. Barouch et al.   NATURE REVIEWS MICROBIOLOGY

Helper Dependent Adenovirus Vectors: Progress and Future Prospects

(2013) Dan Cots et al.   CURRENT GENE THERAPY

Transgene Expression up to 7 Years in Nonhuman Primates Following Hepatic Transduction with Helper-Dependent Adenoviral Vectors

(2013) Nicola Brunetti-Pierri et al.   HUMAN GENE THERAPY

Neonatal Adenoviral Infection: A Seventeen Year Experience and Review of the Literature

(2013) Andrea Ronchi et al.   JOURNAL OF PEDIATRICS

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

(2013) Marc Gurwith et al.   LANCET INFECTIOUS DISEASES

Biopump: Autologous skin-derived micro-organ genetically engineered to provide sustained continuous secretion of therapeutic proteins

(2012) EDUARDO MITRANI et al.   Dermatologic Therapy

Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

(2012) Otto Hemminki et al.   MOLECULAR THERAPY

Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting

(2012) Jun Fu et al.   NATURE BIOTECHNOLOGY

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

(2012) Michael C. Keefer et al.   PLoS One

Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28

(2010) Christoph A. Kahl et al.   VACCINE

Fatal adenovirus infection in a neonate and transmission to health-care workers

(2009) Cécile Henquell et al.   JOURNAL OF CLINICAL VIROLOGY

Phylogeny and primary structure analysis of fiber shafts of all human adenovirus types for rational design of adenoviral gene-therapy vectors

(2009) S. Darr et al.   JOURNAL OF GENERAL VIROLOGY

Enzymatic assembly of DNA molecules up to several hundred kilobases

(2009) Daniel G Gibson et al.   NATURE METHODS

Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines

(2009) Eric A. Weaver et al.   PLoS One

Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function

(2008) Richard J. Stanton et al.   BIOTECHNIQUES

Novel recombinant adenovirus type 41 vector and its biological properties

(2008) Zhuo-Zhuang Lu et al.   JOURNAL OF GENE MEDICINE

Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer

(2008) Irene Kuhn et al.   PLoS One

Modification of Adenovirus Gene Transfer Vectors With Synthetic Polymers: A Scientific Review and Technical Guide

(2007) Florian Kreppel et al.   MOLECULAR THERAPY